← Leaderboards
Matthew R Olson
Purdue University
$746,665
Attributed
$746,665
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $340K · FY2022–24$500K$375K$250K$125K$0
'22
'23
'24
Funding mix
By agency
NIH$746,665 · 2
By mechanism
R21$406,665 · 1
R56$340,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Pathway Interactions”
- Sabrina Paganoni · Massachusetts General Hospital$15,344,018
- Suma Babu · Massachusetts General Hospital$15,344,018
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Stanley Wang · Aligos Therapeutics, Inc.$8,469,477
- Matthew Morrow Engelhard · Duke University$7,519,665
- Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research$7,024,010
Research focus
Pathway InteractionsTissuesIntestinal DiseasesPathologyResponseTargeted TreatmentInflammatoryInterferon Type IiIntestinesPathogenicityProgramsRegulationStat3 GeneCellsImmuneDisease ModelInnovationInsightGenesGenetic TranscriptionMapsNovel TherapeuticsPreventTranscription Factor
Grant awards (3)
A T cell STAT3-BATF axis regulates intestinal gamma delta T cell homeostasis and disease$183,614
R21 · FY2024 · AI · contact PI
A T cell STAT3-BATF axis regulates intestinal gamma delta T cell homeostasis and disease$223,051
R21 · FY2023 · AI · contact PI
Differentiation of pathogenic granzyme A-producing CD4+ T cells in graft-versus-host-disease$340,000
R56 · FY2022 · AI · contact PI